Bulletin 2012/02 - European Patent Office
31.12.2012 • Views
Share Embed Flag

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(2)<br />

(30) 06.03.2009 CN 200910079569<br />

(54) • NEUE VERWENDUNG VON FIBRINOGEN-<br />

420 UND AKTIVER BEREICH DAVON<br />

• Novel uses of fibrinogen-420 and active<br />

domain thereof<br />

• Nouvelles utilisations du fibrinogène-420 et<br />

de son domaine actif<br />

(71) Tsinghua University, Haidian District, Beijing<br />

100084, CN<br />

(72) LUO, Yongzhang, Beijing 100084, CN<br />

TANG, Huadong, Beijing 100084, CN<br />

FU, Yan, Beijing 100084, CN<br />

(74) Woods, Geoffrey Corlett, J.A. Kemp & Co. 14<br />

South Square, Gray's Inn London WC1R 5JJ,<br />

GB<br />

(51) A61K 39/00 (11) 2 404 614 A1<br />

A61P 35/00<br />

(25) En (26) En<br />

(21) 11184308.2 (22) 20.12.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(30) 20.12.2006 US 876222 P<br />

(54) • UNIVERSELLER TUMORZELLENIMPF-<br />

STOFF FÜR ANTIKREBSTHERAPIE- UND<br />

PROPHYLAXEVERWENDUNG<br />

• Universal tumor cell vaccine for anti cancer<br />

therapeutic and prophylactic utilization<br />

• VACCIN UNIVERSEL A BASE DE CELLU-<br />

LES TUMORALES POUR UTILISATION<br />

THERAPEUTIQUE OU PROPHYLACTIQUE<br />

DU CANCER<br />

(71) Novarx, 6828 Nancy Ridge Drive, Suite 100,<br />

San Diego CA 92121-2635, US<br />

(72) Fakhrai, Habib, La Jolla, CA California 92037,<br />

US<br />

Shawler, Daniel L., San Diego, CA California<br />

92126, US<br />

(74) Jansen, Cornelis Marinus, VEREENIGDE<br />

Johan de Wittlaan 7, 2517 JR Den Haag, NL<br />

(62) 07873860.6 / 2 101 812<br />

A61K 39/00 → (51) C12N 15/12<br />

(51) A61K 39/395 (11) 2 404 615 A1<br />

C07K 16/24 C07K 16/46<br />

C07K 16/28<br />

(25) En (26) En<br />

(21) 10011473.5 (22) 23.04.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />

TR<br />

(30) 23.04.2003 US 465058 P<br />

(54) • Humanisierte Antikörper gegen Interferonalpha-Rezeptor-1<br />

(IFNAR-1)<br />

• Humanized antibodies to interferon alpha<br />

receptor-1 (IFNAR-1)<br />

• Anticorps humanisés dirigés contre le<br />

récepteur 1 pour l'interféron alpha (IFNAR-<br />

1)<br />

(71) Medarex, Inc., 707 State Road, Suite 206,<br />

Princeton, NJ 08540-1437, US<br />

(72) Cardarelli, Josephine M., San Carlos CA<br />

94070, US<br />

Chen, Tseng-hui, Timothy, Burlingame CA<br />

94010, US<br />

King, David, Belmont CA 940<strong>02</strong>, US<br />

Bebbinbton, Christopher R., San Mateo CA<br />

944<strong>02</strong>, US<br />

Pogue, Sarah Lee, Fremont CA 944<strong>02</strong>, US<br />

Carr, Francis J., Balmedie Aberdeenshire<br />

AB23 8XU, GB<br />

Williams, Stephen, Alford Aberdeenshire<br />

AB33 8HJ, GB<br />

(74) Chapman, Paul Gilmour, et al, Marks & Clerk<br />

LLP Aurora 120 Bothwell Street, Glasgow G2<br />

7JS, GB<br />

(62) 04750579.7 / 1 631 590<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(51) A61K 39/395 (11) 2 404 616 A2<br />

C07K 16/22 C12N 15/09<br />

(25) En (26) En<br />

(21) 11175663.1 (22) 08.12.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK RS<br />

(30) 13.12.2005 US 750085 P<br />

14.12.2005 US 750772 P<br />

17.<strong>02</strong>.2006 US 774747 P<br />

24.05.2006 US 808183 P<br />

(54) • Für insulinartige Wachstumsfaktoren spezifische<br />

Bindungsproteine und deren Verwendungen<br />

• Binding proteins specific for insulin-like<br />

growth factors and uses thereof<br />

• Protéines de liaison spécifiques pour<br />

facteurs de croissance de type insuline et<br />

leurs utilisations<br />

(71) AstraZeneca AB, 151 85 Södertälje, SE<br />

(72) Cartlidge, Susan Ann, Macclesfield Cheshire<br />

SK10 4TG, GB<br />

Tonge, David William, Macclesfield Cheshire<br />

SK10 4TG, GB<br />

Raeber, Olivia, Redwood City California<br />

94061, US<br />

Gazit-Bornstein, Gadi, Cambridge Massachusetts<br />

<strong>02</strong>141, US<br />

Yang, Xiaodong, Palo Alto California 94306,<br />

US<br />

(74) Bates, Rosica Florence, Medlmmune Ltd.<br />

Milstein Building Granta Park, Cambridge<br />

CB21 6GH, GB<br />

(62) 06848597.8 / 1 979 001<br />

A61K 39/395 → (51) C07H 21/04<br />

A61K 39/395 → (51) C07K 16/24<br />

A61K 39/395 → (51) C07K 16/28<br />

(51) A61K 41/00 (11) 2 404 617 A1<br />

A61P 43/00<br />

(25) En (26) En<br />

(21) 10425231.7 (22) 08.07.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO SE SI SK SM TR<br />

BA ME RS<br />

(54) • Physikalischer Frequenzträger für Diagnosen,<br />

medizinische Therapie und menschliche,<br />

zootechnische und<br />

landwirtschaftliche Verbesserung<br />

• Frequency physical carrier for diagnostics,<br />

medical therapy and human, zootechnical<br />

and agronomic enhancement<br />

• Support physique de fréquence pour le<br />

diagnostic, le traitement médical et l'amélioration<br />

humaine, zootechnique et agricole<br />

(71) Spera, Dario Maximilian, Via dell'Accademia<br />

Albertina, 7, 00147 Roma, IT<br />

(72) Spera, Dario Maximilian, 00147 Roma, IT<br />

(74) Cioncoloni, Giuliana, Studio Consulenza<br />

Brevetti Cioncoloni S.r.l. Via Castrense, 21,<br />

00182 Roma, IT<br />

A61K 45/00 → (51) A61K 31/704<br />

A61K 45/06 → (51) A61K 31/4045<br />

A61K 47/12 → (51) A61K 9/00<br />

A61K 47/32 → (51) A61K 31/198<br />

A61K 47/34 → (51) A61K 31/198<br />

A61K 47/36 → (51) A61K 31/198<br />

185<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>02</strong>/<strong>2012</strong>) 11.01.<strong>2012</strong><br />

A61K 47/36 → (51) A61K 49/00<br />

A61K 47/36 → (51) C12N 15/113<br />

A61K 47/42 → (51) A61K 9/00<br />

(51) A61K 47/48 (11) 2 404 618 A1<br />

A61P 37/<strong>02</strong><br />

(25) En (26) En<br />

(21) 10168747.3 (22) 07.07.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO SE SI SK SM TR<br />

BA ME RS<br />

(54) • Immunomodulatorische Protein-Konstrukte<br />

mit einem helikalen Polymer-Rückgrat<br />

• Immunomodulatory protein constructs<br />

with a helical polymeric backbone.<br />

• Configuration de protéine immunomodulatoire<br />

avec un polymer à squelette hélicale<br />

(71) Stichting Katholieke Universiteit meer in het<br />

bijzonder Radboud Universiteit Nijmegen,<br />

Comeniuslaan 4, 6525 HP Nijmegen, NL<br />

Stichting Katholieke Universiteit, Radboud<br />

Universtiy Nijmegen Medical Centre Geert<br />

Grooteplein 10 P.O. Box 9101, 6500 HB<br />

Nijmegen, NL<br />

(72) Rowan, Alan Edward, 6525 AJ, NIJMEGEN,<br />

NL<br />

Figdor, Carl Gustav, 6525 GA, NIJMEGEN,<br />

NL<br />

(74) Habets, Winand, Life Science <strong>Patent</strong>s PO Box<br />

5096, 6130 PB Sittard, NL<br />

A61K 47/48 → (51) C08B 31/12<br />

A61K 48/00 → (51) C12N 15/00<br />

A61K 48/00 → (51) C12N 15/113<br />

(51) A61K 49/00 (11) 2 404 619 A1<br />

A61K 9/06 A61K 47/36<br />

A61K 6/00 A61K 31/167<br />

A61K 9/00<br />

(25) Fr (26) Fr<br />

(21) 11170986.1 (22) 22.06.2011<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

BA ME<br />

(30) 05.07.2010 FR 1055426<br />

(54) • Injizierbare Zusammensetzung aus einem<br />

injizierbaren Arzneimittel und einem Gel<br />

• Injectable composition composed of an<br />

injectable medication and a gel<br />

• Composition injectable comprenant un<br />

médicament injectable et un gel<br />

(71) Villette, Alain, Les Vannes, 79700 Saint<br />

Pierre Les Echaubrognes, FR<br />

(72) Villette, Alain, 79700 Saint Pierre Les<br />

Echaubrognes, FR<br />

(74) Thinat, Michel, Cabinet Madeuf-Viard, 56A,<br />

rue du Faubourg Saint-Honoré, 75008 Paris,<br />

FR<br />

A61K 49/00 → (51) A01K 67/<strong>02</strong>7<br />

A61K 49/00 → (51) C07C 317/50<br />

A61K 51/00 → (51) C07D 207/404<br />

A61K 51/04 → (51) C07C 317/50<br />

(51) A61L 2/10 (11) 2 404 620 A1<br />

A61B 19/<strong>02</strong><br />

A61L 2/26<br />

A61G 12/00<br />

(25) It (26) En

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!